Selective serotonin reuptake inhibitor
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Selective serotonin reuptake inhibitors)
Selective serotonin reuptake inhibitors or SSRIs are a class of antidepressants]. They increase serotonin levels by blocking the brain's reabsorption of that neurotransmitter.[1] Some SSRIs are also used to treat some other conditions, including some anxiety disorders.[1]
Theory[edit | edit source]
Evidence[edit | edit source]
As of May 2018, the FDA has approved the following SSRIs to treat depression:[1]
- Citalopram (Celexa)
- Escitalopram (Lexapro)
- Fluoxetine (Prozac)
- Paroxetine (Paxil, Pexeva)
- Sertraline (Zoloft)
- Vilazodone (Viibryd)
Fluvoxamine (Luvox) is an SSRI approved to treat obsessive-compulsive disorder and is sometimes also used to treat depression.[1]
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
Costs and availability[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 1.3 "Selective serotonin reuptake inhibitors (SSRIs)". Mayo Clinic. Retrieved January 8, 2019.
